RxSight, Inc. (RXST) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and thank you for standing by. My name is John and I will be your conference operator today. At this time, I would like to welcome everyone to the RxSight preliminary second quarter financial results and product pipeline updates following collaboration agreement. All lights have been placed in mute to prevent any background noise. After the speaker remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. And to withdraw your question, simply press star one again. I would now like to turn the conference over to Oliver Moravcevic, VP of Investor Relations. Please go ahead. Thank you, Operator. With me on the call this morning is RxSight President and Chief Executive Officer, Dr. Ron Kurtz, and Chief Financial Officer, Mark Wilterly. Yesterday, RxSight released a pair of press releases, one reporting on a new collaboration agreement with Alcon, and the second reporting preliminary revenue results for the three months ending June 30, 2026. updated product pipeline, and revised folio guidance. Copies of both press releases and corresponding 8Ks are available on the company's website. Before we begin, I would like to inform you that comments and responses to questions during today's call reflect management's views as of today, July 7, 2026, and will include forward-looking and opinion statements including predictions, estimates, plans, expectations, and other information. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued yesterday and in our filings with the Securities and Exchange Commission or SEC....